Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 08 - 04 tags : Earnings save search
Karyopharm Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress
Published: 2022-08-04 (Crawled : 13:00) - biospace.com/
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: -0.44%
H: 11.16%
C: 1.12%
results
Dyne Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
Published: 2022-08-04 (Crawled : 13:00) - biospace.com/
DYN | $24.98 -1.81% -1.84% 680K
|
Health Technology
|
| O: -1.73%
H: 7.49%
C: 4.92%
therapeutics results
XOMA Reports Second Quarter 2022 Financial Results and Highlights Recent Operational Events
Published: 2022-08-04 (Crawled : 13:00) - biospace.com/
XOMA | $25.11 -3.76% -3.9% 8.2K
|
Health Technology
|
| O: -0.41%
H: 0.6%
C: -6.26%
results
Intellia Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress
Published: 2022-08-04 (Crawled : 13:00) - biospace.com/
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: -1.01%
H: 3.43%
C: 2.04%
NTLA | $21.16 -1.72% -1.75% 860K
|
Health Technology
|
| O: -13.67%
H: 6.45%
C: 5.7%
therapeutics results
Ironwood Pharmaceuticals Reports Second Quarter 2022 Results; Maintains Full Year Guidance Due to Continued Strength of LINZESS® Prescription Demand
Published: 2022-08-04 (Crawled : 13:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.29%
H: 0.34%
C: -2.23%
IRWD | $8.11 -2.41% -2.47% 1.9M
|
Health Technology
|
| O: -0.98%
H: 3.78%
C: 3.42%
linzess year
Edgewise Therapeutics Reports Second Quarter 2022 Financial Results
Published: 2022-08-04 (Crawled : 13:00) - biospace.com/
EWTX | $16.08 2.75% 2.67% 430K
|
Manufacturing
|
| O: 0.22%
H: 10.85%
C: 10.09%
therapeutics results
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2022Conference Call Scheduled for Friday, August 12, 2022 at 9:00 AM ET
Published: 2022-08-04 (Crawled : 12:00) - biospace.com/
ICCC | $5.12 1.79% 1.76% 7.2K
|
Health Technology
|
| O: -1.0%
H: 0.0%
C: -0.45%
Affimed to Report Second Quarter 2022 Financial Results & Corporate Update on August 11, 2022
Published: 2022-08-04 (Crawled : 12:00) - biospace.com/
AFMD | $4.91 -8.22% -8.96% 65K
|
Health Technology
|
| O: 1.01%
H: 9.0%
C: 9.0%
report update results
InfuSystem Reports Second Quarter 2022 Financial Results
Published: 2022-08-04 (Crawled : 12:00) - biospace.com/
STMH | $0.1 -88.3% 2.2K
|
Manufacturing
|
| O: 1.47%
H: 0.0%
C: -13.04%
results
Sol-Gel Technologies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-04 (Crawled : 12:00) - biospace.com/
SLGL | $0.92 -0.56% -0.57% 7.6K
|
Health Technology
|
| O: -2.8%
H: 2.54%
C: -3.95%
update results
Pieris Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-04 (Crawled : 12:00) - biospace.com/
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: -2.2%
H: 1.12%
C: -3.37%
update results
ABIOMED Announces First Quarter Record Revenue of $277 Million, up 10% Year Over Year, up 12% in Constant Currency*
Published: 2022-08-04 (Crawled : 12:00) - biospace.com/
ABMD | $381.02 0.06% 0.07%
|
Health Technology
|
| O: 1.99%
H: 0.0%
C: -2.65%
year
BeiGene Reports Second Quarter 2022 Financial Results
Published: 2022-08-04 (Crawled : 12:00) - biospace.com/
BGNE | $144.0 3.61% 3.48% 220K
|
Health Technology
|
| O: 4.88%
H: 8.92%
C: 7.35%
results
AlloVir Reports Second Quarter 2022 Financial Results
Published: 2022-08-04 (Crawled : 12:00) - biospace.com/
ALVR | $0.7826 -1.05% -1.06% 150K
|
Health Technology
|
| O: -0.86%
H: 13.54%
C: 13.19%
results
Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2022 Financial Results
Published: 2022-08-04 (Crawled : 12:00) - biospace.com/
DCPH | $14.6 -0.48% -0.48% 320K
|
Health Technology
|
| O: -1.62%
H: 27.12%
C: 25.92%
results
Bicycle Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-04 (Crawled : 12:00) - biospace.com/
BCYC | $22.7 0.09% 0.09% 520K
|
Health Technology
|
| O: -0.61%
H: 13.4%
C: 11.82%
therapeutics bicycle update results
Concert Pharmaceuticals Reports Second Quarter 2022 Financial Results
Published: 2022-08-04 (Crawled : 12:00) - biospace.com/
CNCE | $8.37 0.36% 0
|
Health Technology
|
| O: -0.65%
H: 5.41%
C: 0.82%
results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.